Drug:
Reaction: COVID-19
20250101 - 20251231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 25830807 |
US |
61 | 2 |
COVID-19, |
||||
SARILUMAB, ERGOCALCIFEROL, |
||||
| 202 | 25830996 |
US |
||
Syncope, COVID-19, |
||||
CLADRIBINE, CLADRIBINE, |
||||
| 203 | 25831073 |
US |
||
COVID-19, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 204 | 25831094 |
GB |
1 | |
Hospitalisation, Malaise, COVID-19, Treatment noncompliance, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, |
||||
| 205 | 25831233 |
CN |
72 | 2 |
Death, COVID-19, Off label use, |
||||
BRENTUXIMAB VEDOTIN, INDAPAMIDE, |
||||
| 206 | 25831236 |
CA |
34 | 2 |
Arrhythmia, Scab, Oral herpes, COVID-19, Fatigue, Off label use, |
||||
RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, PROPRANOLOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 207 | 25831255 |
US |
1 | |
Systemic lupus erythematosus, COVID-19, |
||||
BELIMUMAB, |
||||
| 208 | 25831551 |
CA |
58 | 1 |
COVID-19, Cough, Off label use, Sinusitis, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE, |
||||
| 209 | 25831676 |
US |
36 | 2 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 210 | 25831713 |
US |
58 | 1 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 211 | 25831779 |
US |
34 | 2 |
Serotonin syndrome, COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, BUPROPION HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MAGNESIUM, LEVOTHYROXINE, |
||||
| 212 | 25831888 |
US |
76 | 1 |
COVID-19, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 213 | 25832294 |
AU |
||
Complication of device removal, Device breakage, COVID-19, |
||||
ESTRADIOL, |
||||
| 214 | 25832415 |
CA |
32 | 2 |
Pulmonary embolism, COVID-19, Cardiac disorder, |
||||
INFLIXIMAB, |
||||
| 215 | 25832873 |
79 | 2 | |
Fall, COVID-19, |
||||
AMLODIPINE, CARVEDILOL, FUROSEMIDE, LEVOTHYROXINE, TIRZEPATIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 216 | 25832904 |
CA |
71 | 1 |
Basal cell carcinoma, Blood test abnormal, COVID-19, Chest pain, Dizziness, Glaucoma, Headache, Nasopharyngitis, Off label use, Pulmonary fibrosis, Tooth disorder, |
||||
NITROGLYCERIN, INFLIXIMAB-AXXQ, INFLIXIMAB-AXXQ, INFLIXIMAB-AXXQ, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 217 | 25833068 |
CA |
68 | 2 |
Inappropriate schedule of product administration, Myocardial infarction, Rheumatoid arthritis, COVID-19, Dyspnoea, Heart rate increased, Hypersensitivity, Nausea, Pain, Rash, Rash erythematous, Rash macular, Therapeutic response shortened, |
||||
FLUCONAZOLE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 218 | 25833209 |
66 | ||
COVID-19, |
||||
RUXOLITINIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, DULOXETINE HYDROCHLORIDE, DULOXETINE, FERROUS SULFATE, FOLIC ACID, GABAPENTIN, HYDROCHLOROTHIAZIDE, LATANOPROST, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOPROLOL, ROSUVASTATIN, CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 219 | 25833479 |
EU |
63 | 1 |
Hospitalisation, Influenza, COVID-19, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BORTEZOMIB FOR INJECTION, BORTEZOMIB, POMALIDOMIDE, |
||||
| 220 | 25833714 |
US |
||
Bronchial disorder, Pyrexia, Vomiting, Chest discomfort, Neoplasm malignant, COVID-19, Dysstasia, |
||||
RAVULIZUMAB, |
||||
| 221 | 25836198 |
75 | 2 | |
COVID-19, |
||||
ABALOPARATIDE, |
||||
| 222 | 25836205 |
56 | 2 | |
COVID-19, Pneumonia, |
||||
BELIMUMAB, |
||||
| 223 | 25827805 |
US |
55 | 2 |
COVID-19, Conjunctivitis, |
||||
DUPILUMAB, |
||||
| 224 | 25828085 |
CA |
55 | 1 |
Pneumonia, Influenza, COVID-19, Pharyngitis streptococcal, |
||||
PREDNISONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ABATACEPT, |
||||
| 225 | 25828438 |
CA |
44 | 2 |
Lower respiratory tract infection, Illness, Off label use, Loss of personal independence in daily activities, COVID-19, Ankylosing spondylitis, |
||||
PREDNISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, |
||||
| 226 | 25832610 |
56 | 1 | |
COVID-19, |
||||
AXITINIB, |
||||
| 227 | 25826411 |
GB |
2 | |
COVID-19, Rheumatoid arthritis, Chronic obstructive pulmonary disease, |
||||
CERTOLIZUMAB PEGOL, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 228 | 25826852 |
US |
66 | 1 |
Bronchitis, Nasopharyngitis, COVID-19, Ear infection, Parainfluenzae virus infection, |
||||
LENALIDOMIDE, |
||||
| 229 | 25826853 |
JP |
57 | 1 |
Idiopathic pulmonary fibrosis, Drug-induced liver injury, COVID-19, Neutrophil count decreased, Exercise tolerance decreased, PO2 decreased, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, NINTEDANIB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, PIRFENIDONE, |
||||
| 230 | 25826945 |
EU |
||
Respiratory failure, Haemorrhage, COVID-19, Atrial fibrillation, Neutropenia, Tachycardia, COVID-19 pneumonia, Pericarditis, Bladder transitional cell carcinoma, Rectal haemorrhage, Haematuria, Herpes zoster reactivation, Atrial flutter, Infection, Thrombocytopenia, Stoma site haemorrhage, |
||||
IBRUTINIB, ZANUBRUTINIB, |
||||
| 231 | 25826983 |
EU |
30 | 1 |
COVID-19, Peritonitis, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYCLOSPORINE, PREDNISONE, OBINUTUZUMAB, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OBINUTUZUMAB, CYCLOSPORINE, |
||||
| 232 | 25826985 |
JP |
||
Renal failure, Infection, Viral infection, COVID-19, Haemorrhage, Pneumonia bacterial, Thrombocytopenia, Hepatic function abnormal, Skin cancer, Diarrhoea, Bacteraemia, Mucosal inflammation, Cellulitis, Cytomegalovirus infection, Superior mesenteric artery syndrome, Renal abscess, Idiopathic pneumonia syndrome, Pneumonia fungal, Palpitations, Renal impairment, Obliterative bronchiolitis, Enteritis, |
||||
IBRUTINIB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 233 | 25826994 |
CA |
||
Arthritis, Eyelid pain, Eyelid ptosis, Fluid retention, Irritability, Pain in extremity, Swelling of eyelid, Thirst, Visual field defect, COVID-19, Viral infection, Nausea, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 234 | 25827040 |
US |
35 | 2 |
Bone graft, COVID-19, Tooth extraction, |
||||
RISANKIZUMAB-RZAA, |
||||
| 235 | 25820079 |
EU |
71 | 1 |
COVID-19, Leukopenia, Inflammatory marker increased, Arthritis, Haemoglobin decreased, Anaemia, Psoriasis, |
||||
UPADACITINIB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 236 | 25820303 |
US |
1 | |
COVID-19, |
||||
MEPOLIZUMAB, |
||||
| 237 | 25820582 |
EU |
42 | 2 |
Arteriovenous fistula thrombosis, Polyomavirus-associated nephropathy, Disease recurrence, COVID-19, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 238 | 25820682 |
US |
69 | 1 |
COVID-19, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 239 | 25820964 |
EU |
42 | 2 |
Polyomavirus-associated nephropathy, Arteriovenous fistula thrombosis, COVID-19, Disease recurrence, |
||||
MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 240 | 25821157 |
US |
39 | 2 |
COVID-19, |
||||
AVAPRITINIB, |
||||
| 241 | 25821256 |
US |
1 | |
COVID-19, Blood sodium decreased, |
||||
IBRUTINIB, |
||||
| 242 | 25821269 |
US |
||
COVID-19, |
||||
BUROSUMAB, |
||||
| 243 | 25821464 |
EU |
1 | |
Hospitalisation, Influenza, COVID-19, |
||||
BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, POMALIDOMIDE, |
||||
| 244 | 25821740 |
CA |
48 | 2 |
Allergy to plants, Anaphylactic reaction, COVID-19, Back pain, Weight decreased, Headache, Drug hypersensitivity, Fatigue, Feeling abnormal, Flushing, Gastrointestinal disorder, Diarrhoea, Hypersensitivity, Illness, Immunisation reaction, Influenza like illness, Malaise, Muscle spasms, Nasopharyngitis, Nausea, Nervousness, Pharyngeal enanthema, Pharyngeal swelling, Rash, Pruritus, SARS-CoV-2 test positive, Tremor, Urticaria, Inappropriate schedule of product administration, Drug ineffective, Therapeutic response shortened, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LORAZEPAM, LORAZEPAM, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CROMOLYN SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 245 | 25822165 |
US |
||
COVID-19, |
||||
PHENTERMINE AND TOPIRAMATE, PHENTERMINE AND TOPIRAMATE, |
||||
| 246 | 25822214 |
US |
||
COVID-19, Taste disorder, |
||||
PHENTERMINE AND TOPIRAMATE, PHENTERMINE AND TOPIRAMATE, |
||||
| 247 | 25822368 |
US |
||
COVID-19, |
||||
PHENTERMINE AND TOPIRAMATE, PHENTERMINE AND TOPIRAMATE, |
||||
| 248 | 25822374 |
EU |
63 | 1 |
Lower respiratory tract infection, Limb discomfort, Rash maculo-papular, Infusion site swelling, Feeling abnormal, COVID-19, Irritability, Muscular weakness, Paraesthesia, Fatigue, Pain, Needle issue, Device infusion issue, Erythema, Feeling hot, Product preparation issue, Incorrect dose administered, |
||||
PRAMIPEXOLE, QUININE SULFATE, QUININE, TIZANIDINE HYDROCHLORIDE, KETOCONAZOLE, |
||||
| 249 | 25822398 |
US |
1 | |
Pneumothorax, COVID-19, Pneumonia, |
||||
VAMOROLONE, VAMOROLONE, PREDNISONE, PREDNISONE, |
||||
| 250 | 25822533 |
US |
||
COVID-19, |
||||
PHENTERMINE AND TOPIRAMATE, |
||||
| 251 | 25822735 |
US |
||
COVID-19, Sinusitis, Nausea, |
||||
PHENTERMINE AND TOPIRAMATE, PHENTERMINE AND TOPIRAMATE, |
||||
| 252 | 25822737 |
US |
||
COVID-19, |
||||
PHENTERMINE AND TOPIRAMATE, |
||||
| 253 | 25822843 |
US |
||
COVID-19, Nausea, Paraesthesia, Cough, |
||||
PHENTERMINE AND TOPIRAMATE, PHENTERMINE AND TOPIRAMATE, PHENTERMINE AND TOPIRAMATE, NIRMATRELVIR AND RITONAVIR, BISMUTH SUBSALICYLATE, |
||||
| 254 | 25822994 |
BR |
25 | 1 |
Blood creatine abnormal, COVID-19, Cardiomegaly, Renal disorder, Weight fluctuation, Weight decreased, Muscle spasms, Product availability issue, Product dose omission issue, Off label use, Myalgia, Headache, Asthenia, Pain, |
||||
IDURSULFASE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 255 | 25823003 |
CA |
60 | 1 |
Pneumonia bacterial, Hypertension, Diabetic wound, Nasal congestion, Aggression, Haemorrhoids, Neck pain, Contusion, Impatience, Hyperhidrosis, Skin laceration, Pain, Arthralgia, Drug ineffective, Scratch, Fall, Fatigue, Loss of consciousness, Haemorrhoid operation, COVID-19, Vomiting, |
||||
MORPHINE SULFATE, PREGABALIN, DULOXETINE HYDROCHLORIDE, DULOXETINE, GABAPENTIN, LIRAGLUTIDE, MORPHINE SULFATE, PANTOPRAZOLE, PANTOPRAZOLE, INSULIN DEGLUDEC, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FENOFIBRATE, INSULIN LISPRO, METHADONE HYDROCHLORIDE, METHADONE, INDOMETHACIN, FENTANYL, |
||||
| 256 | 25823223 |
US |
||
COVID-19, Weight decreased, |
||||
PHENTERMINE AND TOPIRAMATE, |
||||
| 257 | 25823327 |
US |
||
COVID-19, Bronchial disorder, |
||||
PHENTERMINE AND TOPIRAMATE, PHENTERMINE AND TOPIRAMATE, |
||||
| 258 | 25823424 |
US |
||
COVID-19, |
||||
PHENTERMINE AND TOPIRAMATE, |
||||
| 259 | 25823575 |
GB |
77 | 2 |
Eye operation, COVID-19, |
||||
RISANKIZUMAB-RZAA, |
||||
| 260 | 25823878 |
US |
70 | 1 |
COVID-19, Contraindicated product administered, Blood pressure decreased, Balance disorder, Blood pressure increased, Insomnia, Abnormal weight gain, |
||||
PREDNISONE, |
||||
| 261 | 25823996 |
CA |
71 | 2 |
Lower respiratory tract infection, Faeces discoloured, Toothache, Nasopharyngitis, Pyrexia, Paraesthesia, Haematochezia, Rash, Pharyngitis streptococcal, Road traffic accident, COVID-19, Bronchitis, Pruritus, Urticaria, Decreased appetite, Mucous stools, Chills, Headache, Cough, Diarrhoea, Ear disorder, |
||||
METHYLPREDNISOLONE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ROSUVASTATIN CALCIUM, DEXLANSOPRAZOLE, PREDNISONE, MESALAMINE, ERGOCALCIFEROL, LEVOTHYROXINE SODIUM, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, CICLESONIDE, |
||||
| 262 | 25824047 |
US |
76 | 2 |
COVID-19, |
||||
LENALIDOMIDE, |
||||
| 263 | 25824189 |
CA |
66 | 1 |
Renal impairment, Blood immunoglobulin E increased, Eosinophil count increased, Mean cell volume increased, Red blood cell sedimentation rate increased, Total lung capacity decreased, Asthma, Product dose omission issue, Drug ineffective, Glaucoma, COVID-19, Throat clearing, Dry throat, Dysphonia, Dyspepsia, Eructation, Rhinitis, Middle insomnia, Nasal congestion, Rhinorrhoea, Upper-airway cough syndrome, Obstructive airways disorder, Rhinitis allergic, Pulmonary congestion, Cough, Dyspnoea, Wheezing, Chest discomfort, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, TELMISARTAN, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, LOSARTAN POTASSIUM, |
||||
| 264 | 25824651 |
US |
2 | |
COVID-19, Pyrexia, |
||||
DUPILUMAB, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, EPINEPHRINE, ADRENALINUM, ALENDRONATE SODIUM, BUPROPION HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ROSUVASTATIN CALCIUM, LEVOTHYROXINE SODIUM, ESCITALOPRAM, ALBUTEROL SULFATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 265 | 25824689 |
US |
||
COVID-19, Dyspnoea, |
||||
ROMOSOZUMAB-AQQG, DENOSUMAB, ZOLEDRONIC ACID, |
||||
| 266 | 25824758 |
US |
50 | 1 |
COVID-19, Turbinectomy, Gastrooesophageal reflux disease, Injection site haemorrhage, |
||||
DUPILUMAB, MENTHOL, TAURINE, POLYETHYLENE GLYCOL 400, MELATONIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ALBUTEROL SULFATE, ANASTROZOLE, ANASTROZOLE TABLETS, CETIRIZINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, GABAPENTIN, TESTOSTERONE, TESTOSTERONE,, |
||||
| 267 | 25824868 |
US |
52 | 2 |
Autoimmune disorder, Neoplasm malignant, Pain, Illness, COVID-19, |
||||
TOFACITINIB, |
||||
| 268 | 25824907 |
US |
68 | 1 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 269 | 25824928 |
US |
38 | 1 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 270 | 25825131 |
US |
||
Crohn^s disease, Rheumatoid arthritis, COVID-19, |
||||
PHENTERMINE AND TOPIRAMATE, |
||||
| 271 | 25825345 |
US |
77 | 1 |
Somnolence, COVID-19, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 272 | 25825475 |
EU |
66 | 2 |
Death, COVID-19, Off label use, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
| 273 | 25825680 |
US |
||
COVID-19, Insomnia, |
||||
DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, VALSARTAN, VALSARTAN ORAL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 274 | 25825879 |
US |
2 | |
COVID-19, Feeling abnormal, Memory impairment, |
||||
TOFACITINIB, SECUKINUMAB, |
||||
| 275 | 25831070 |
60 | 2 | |
COVID-19, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 276 | 25814899 |
US |
1 | |
COVID-19, Pulmonary hypertension, Hypersomnia, Cough, Off label use, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TADALAFIL, RIVAROXABAN, FOLIC ACID, MACITENTAN, NINTEDANIB, ERGOCALCIFEROL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, OXYGEN, 0XYGEN, RIVASTIGMINE, FUROSEMIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 277 | 25815168 |
CA |
61 | 2 |
Blood glucose increased, COVID-19, Diabetes mellitus, Feeling abnormal, Fungal infection, Herpes zoster, Nasopharyngitis, Nausea, Periarthritis, Rash, Urinary tract infection, Drug effective for unapproved indication, Drug ineffective, Off label use, |
||||
VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, AZATHIOPRINE, AZATHIOPRINE, BELIMUMAB, BELIMUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, |
||||
| 278 | 25815526 |
US |
2 | |
Arteriosclerosis coronary artery, Syncope, Loss of consciousness, Gastrooesophageal reflux disease, Rhinorrhoea, Cough, Nasal dryness, Illness, Sleep apnoea syndrome, Paranasal sinus discomfort, Paranasal sinus hypersecretion, Urinary tract infection, Epistaxis, COVID-19, Asthma, Chest pain, Dysphonia, Feeling hot, Cold sweat, Palpitations, Bloody discharge, |
||||
DENOSUMAB, PREDNISONE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUPROPION HYDROCHLORIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, CIPROFLOXACIN AND DEXAMETHASONE, CLONAZEPAM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FAMOTIDINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, IPRATROPIUM BROMIDE, LINACLOTIDE, MECLIZINE HCL 12.5 MG, MECLIZINE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, MONTELUKAST, OFLOXACIN, OFLOXACIN OTIC, OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3%, OFLOXACIN OTIC SOLUTION, PANTOPRAZOLE, POTASSIUM CITRATE, VITAMIN E, |
||||
| 279 | 25815788 |
US |
1 | |
COVID-19, |
||||
PERAMPANEL, |
||||
| 280 | 25815834 |
US |
1 | |
COVID-19, |
||||
PERAMPANEL, |
||||
| 281 | 25816341 |
EU |
77 | 2 |
Malignant neoplasm progression, Blood thyroid stimulating hormone decreased, Chest pain, COVID-19, Medical device site infection, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, DOSTARLIMAB, DOSTARLIMAB, |
||||
| 282 | 25816825 |
US |
2 | |
COVID-19, Product dose omission issue, Underdose, |
||||
TROFINETIDE, |
||||
| 283 | 25817201 |
US |
1 | |
Oropharyngeal pain, Influenza, COVID-19, |
||||
TIRZEPATIDE, |
||||
| 284 | 25817289 |
US |
51 | 2 |
COVID-19, Product dose omission in error, |
||||
TOFACITINIB, TOFACITINIB, UPADACITINIB, |
||||
| 285 | 25817292 |
US |
67 | 2 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, ROSUVASTATIN, EZETIMIBE, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, |
||||
| 286 | 25817324 |
US |
77 | 1 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 287 | 25817375 |
EU |
42 | 2 |
Arteriovenous fistula thrombosis, Polyomavirus-associated nephropathy, COVID-19, Disease recurrence, |
||||
PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 288 | 25817532 |
US |
48 | 1 |
COVID-19, Swelling, Arthralgia, Groin pain, Intentional dose omission, Gait disturbance, |
||||
BUDESONIDE, ALBUTEROL SULFATE, ALBUTEROL, ALLOPURINOL, BUPROPION HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, MELATONIN, METOPROLOL TARTRATE, METOPROLOL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PIOGLITAZONE, TADALAFIL, |
||||
| 289 | 25817673 |
US |
77 | 2 |
Clostridium difficile infection, COVID-19, Escherichia infection, |
||||
TECLISTAMAB, |
||||
| 290 | 25817758 |
US |
36 | 1 |
COVID-19, Chest discomfort, |
||||
SPARSENTAN, |
||||
| 291 | 25817776 |
EU |
66 | 2 |
Death, COVID-19, |
||||
BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 292 | 25817793 |
US |
76 | 1 |
COVID-19, Off label use, |
||||
BEVACIZUMAB-AWWB, |
||||
| 293 | 25817798 |
US |
66 | 2 |
Clostridium difficile infection, Blood pressure increased, Heart rate increased, Platelet count increased, Infection, Atrophy, Hyporeflexia, Dizziness, Dysphoria, Secondary progressive multiple sclerosis, Orthostatic hypotension, Muscle spasticity, COVID-19, Uhthoff^s phenomenon, |
||||
CLADRIBINE, CLADRIBINE, CLADRIBINE, CLADRIBINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, DESONIDE, INSULIN GLARGINE, DULAGLUTIDE, SITAGLIPTIN, TIMOLOL MALEATE, TRAVOPROST, TRAVOPROST (ISOMER FREE), BRIMONIDINE TARTRATE, GUAIFENESIN, ATORVASTATIN CALCIUM, |
||||
| 294 | 25817984 |
US |
30 | 2 |
COVID-19, Product dose omission issue, Muscle spasms, |
||||
BUDESONIDE, ALBUTEROL SULFATE, ALBUTEROL, DAPAGLIFLOZIN, IRBESARTAN, METOPROLOL TARTRATE, METOPROLOL, NIFEDIPINE, CARVEDILOL, |
||||
| 295 | 25818140 |
US |
2 | |
Dyspnoea, COVID-19, Pneumonitis, Thrombosis, Underdose, |
||||
OLAPARIB, |
||||
| 296 | 25818177 |
EU |
56 | 1 |
Polyarthritis, Pericarditis, COVID-19, Off label use, |
||||
INFLIXIMAB, |
||||
| 297 | 25818502 |
EU |
42 | 2 |
Arteriovenous fistula thrombosis, Polyomavirus-associated nephropathy, COVID-19, Disease recurrence, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 298 | 25818639 |
70 | 1 | |
COVID-19, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 299 | 25818726 |
US |
72 | 2 |
COVID-19, |
||||
DUPILUMAB, |
||||
| 300 | 25818747 |
US |
59 | 1 |
COVID-19, |
||||
TOFACITINIB, ETANERCEPT, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30